134 related articles for article (PubMed ID: 35117819)
1. MiRNA 3613-5p and MiRNA 3916 rescued the inhibition of cell migration in CNOT2 depleted MDA-MD-231 cells.
Sohn EJ
Transl Cancer Res; 2020 Aug; 9(8):4542-4549. PubMed ID: 35117819
[TBL] [Abstract][Full Text] [Related]
2. CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells.
Sohn EJ; Jung DB; Lee H; Han I; Lee J; Lee H; Kim SH
Cancer Lett; 2018 Jan; 412():88-98. PubMed ID: 29024811
[TBL] [Abstract][Full Text] [Related]
3. Differences of time-dependent microRNA expressions in breast cancer cells.
Bozkurt SB; Ozturk B; Kocak N; Unlu A
Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
5. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.
Kuehbacher A; Urbich C; Zeiher AM; Dimmeler S
Circ Res; 2007 Jul; 101(1):59-68. PubMed ID: 17540974
[TBL] [Abstract][Full Text] [Related]
6. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
[TBL] [Abstract][Full Text] [Related]
11. Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression.
Noh H; Hong S; Dong Z; Pan ZK; Jing Q; Huang S
Genes Cancer; 2011 Feb; 2(2):140-50. PubMed ID: 21779487
[TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
14. The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer.
Dastmalchi N; Azarbarzin S; Safaralizadeh R; Khojasteh SMB; Shadbad MA; Amini M; Baghbanzadeh A; Asl ER; Baghbani E; Lotfinejad P; Baradaran B
Med Oncol; 2021 Nov; 39(1):9. PubMed ID: 34761351
[TBL] [Abstract][Full Text] [Related]
15. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
19. miR-532-5p promotes breast cancer proliferation and migration by targeting RERG.
Huang L; Tang X; Shi X; Su L
Exp Ther Med; 2020 Jan; 19(1):400-408. PubMed ID: 31853317
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
